Flotufolastat F-18 Injection

DRUG2 trials

Sponsors

Sinotau Pharmaceutical Group

Conditions

Prostate Cancer

Phase 1

A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults

RecruitingNCT07149831

Sinotau Pharmaceutical GroupProstate Cancer

Start: 2025-06-07End: 2025-12-31Target: 6Updated: 2025-09-02

Unknown Phase

Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer

RecruitingNCT07115277

Sinotau Pharmaceutical GroupProstate Cancer

Start: 2025-03-14End: 2026-12-31Target: 121Updated: 2025-08-11